Cargando…

G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer

BACKGROUND: Eukaryotic histone methyltransferases 2 (EHMT2 or G9A) has been regarded as a potential target for non-small cell lung cancer (NSCLC) therapy. This study investigated the regulatory roles of G9A in tumorigenesis and stemness in NSCLC. We isolated and enriched tumor-initiating cells (TIC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pangeni, Rajendra P., Yang, Lu, Zhang, Keqiang, Wang, Jinhui, Li, Wendong, Guo, Chao, Yun, Xinwei, Sun, Ting, Wang, Jami, Raz, Dan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302379/ https://www.ncbi.nlm.nih.gov/pubmed/32552834 http://dx.doi.org/10.1186/s13148-020-00879-5

Ejemplares similares

Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer
por: Zhang, Keqiang, et al.
Publicado: (2018)

Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression
por: Sun, Ting, et al.
Publicado: (2022)

Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer
por: Zhang, Keqiang, et al.
Publicado: (2019)

Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II
por: Zhang, Keqiang, et al.
Publicado: (2020)

Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells
por: Yao, J, et al.
Publicado: (2016)

De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes
por: Epsztejn-Litman, Silvina, et al.
Publicado: (2008)

Abstract QS51: Skeletal Muscle Regeneration by Fibromodulin Reprogrammed Cells without Tumorigenic Risks
por: Ha, Pin, et al.
Publicado: (2018)

Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency based reprogramming
por: Zhang, Xi, et al.
Publicado: (2012)

Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
por: Poli, Vittoria, et al.
Publicado: (2018)

Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
por: Carrió, Meritxell, et al.
Publicado: (2019)

Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
por: Carrió, Meritxell, et al.
Publicado: (2019)

Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
por: Zhang, Keqiang, et al.
Publicado: (2023)

UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
por: Wang, Yanchen, et al.
Publicado: (2023)

Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease
por: Young, Juan I., et al.
Publicado: (2019)

The Dynamics of Genome-wide DNA Methylation Reprogramming in Mouse Primordial Germ Cells
por: Seisenberger, Stefanie, et al.
Publicado: (2012)

Genome-wide DNA methylation dynamics during epigenetic reprogramming in the porcine germline
por: Gómez-Redondo, Isabel, et al.
Publicado: (2021)

Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
por: Thng, Dexter Kai Hao, et al.
Publicado: (2023)

LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer
por: Sun, Zeguo, et al.
Publicado: (2022)

Reprogramming of the Genome-Wide DNA Methylation Landscape in Three-Dimensional Cancer Cell Cultures
por: Heredia-Mendez, Alma Jaqueline, et al.
Publicado: (2023)

Tumor Microenvironment Uses a Reversible Reprogramming of Mesenchymal Stromal Cells to Mediate Pro-tumorigenic Effects
por: Nwabo Kamdje, Armel H., et al.
Publicado: (2020)

MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma
por: Huang, Tianzhi, et al.
Publicado: (2017)

Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma
por: Yin, De-Pei, et al.
Publicado: (2023)

Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure
por: Pepin, Mark E., et al.
Publicado: (2018)

Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies
por: Jensen, Emil D., et al.
Publicado: (2017)

Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity
por: Iftikhar, Rida, et al.
Publicado: (2021)

“Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition
por: Nushtaeva, Anna, et al.
Publicado: (2023)

Genome-Wide Dynamic Profiling of Histone Methylation during Nuclear Transfer-Mediated Porcine Somatic Cell Reprogramming
por: Cao, Zubing, et al.
Publicado: (2015)

Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth
por: Lemmetyinen, Toni T., et al.
Publicado: (2023)

Genome-wide methylation analyses identifies Non-coding RNA genes dysregulated in breast tumours that metastasise to the brain
por: Pangeni, Rajendra P., et al.
Publicado: (2022)

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway
por: Zheng, Yin-Li, et al.
Publicado: (2019)

Association of cord blood methylation with neonatal leptin: An epigenome wide association study
por: Kadakia, Rachel, et al.
Publicado: (2019)

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9
por: Fu, Yongyao, et al.
Publicado: (2022)

The Jak2 Small Molecule Inhibitor, G6, Reduces the Tumorigenic Potential of T98G Glioblastoma Cells In Vitro and In Vivo
por: Baskin, Rebekah, et al.
Publicado: (2014)

Correction: Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity
por: Iftikhar, Rida, et al.
Publicado: (2022)

SPOP mutation induces DNA methylation via stabilizing GLP/G9a
por: Zhang, Jianong, et al.
Publicado: (2021)

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines
por: Jimenez, Rosa H., et al.
Publicado: (2009)

Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells
por: Rappa, Germana, et al.
Publicado: (2015)

The DNMT1-associated lincRNA DACOR1 reprograms genome-wide DNA methylation in colon cancer
por: Somasundaram, Saigopal, et al.
Publicado: (2018)

Global Signaling Profiling in a Human Model of Tumorigenic Progression Indicates a Role for Alternative RNA Splicing in Cellular Reprogramming
por: Caruso, Joseph A., et al.
Publicado: (2018)

Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells
por: Liu, Menghan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dp8dec9qium93vvienb744vf26